Ohio’s Cannabis Licensing Requirements: Racial Justice or Discrimination?


Avraham Cohn

August 29th, 2016

Policy, Top News


Staying true to form, Cannabis has once again proven itself to be both controversial and deeply divisive.  In June 2016, Ohio passed its Substitute House Bill 523 which legalized the cultivation, sale, and use of Cannabis by authorized companies and individuals.  The mechanics and full regulatory provisions of the licensing process have yet to be released but to the chagrin of some (and delight of others), the bill calls for 15% of its dispensary, processor, cultivator, and laboratory licenses to be reserved for minority groups.  Specifically, the bill designates the targeted minority groups as those individuals who are ethnically Black, Asian, Hispanic, or Native American.

Naturally, depending on one’s political orientation and broader perception of the alleged institutionalized economic barriers minority groups face, this provision is either encouraging or highly disconcerting.   Of course, this particular social discussion is beyond the scope of this article and instead, we will strictly consider the constitutional issues at play when racially based legislation is passed.

The equal protection clause of the 14th amendment was originally instituted as a tool to combat racial discrimination and asserts:

No state shall make or enforce any law, which shall abridge the privileges or immunities of citizens of the United States; nor shall any state deprive any person of life, liberty, or property, without due process of law; nor deny to any person within its jurisdiction the equal protection of the laws.

The critical clause of the amendment for our purposes is the provision asserting that a person cannot be denied the equal protection of the law.  Simply, the law must be applied to everyone uniformly and in the event that an individual is excluded from a legal right as a function of his race, the 14th amendment is (usually) violated. Indeed, the court will nearly always strike down a racially based law upon applying its formidable strict scrutiny standard of review (requiring the Government to prove the law is necessarily and narrowly tailored to achieve a compelling government interest – this is a virtually unattainable feat).

Here, the 15% licensing requirement for minority groups will necessarily mean that whites and other individuals who are not members of the designated protected classes will not be able to secure licenses because of their race.  Ostensibly, this would seem to be a clear 14th amendment violation – after all, these unprotected classes are being discriminated against and are not afforded the same rights as the designated minority groups simply because they were not born to the correct racial/ethnic group.

Proponents of this provision have and will continue to argue that this 15% licensing requirement is merely a remedial measure meant to combat decades of racial injustice and is no different than any other affirmative action schema whereby the government affords special protections and advantages to historically disenfranchised groups.  Thus, the licensing requirement is not discriminating against whites, in as much as it is leveling the playing field for otherwise underprivileged minorities.

Opponents, conversely, will note that the Supreme Court has only upheld affirmative action plans for government contracting when there is a clear record of racial injustice.  As this is the first medical marijuana bill enacted in the State of Ohio, there is no precedent whereby it can be shown that minority groups were discriminated against.  Finally, opponents will further argue that there is a significant difference between permitting affirmative action plans whereby the government spends its money, in the form of issuing contracts, and not allowing whites to apply for a given type of license.

Ultimately, it is impossible to know how a Supreme Court would rule if the case ended up in its chambers but regardless, history will be made and important precedents will be set.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Avraham Cohn

About Avraham Cohn

Abe Cohn is COO of THC Legal Group, a law practice specializing in intellectual property protection for the cannabis industry. For more information, please visit their website at http://www.THCLegalGroup.com.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading